Encompass Health increases quarterly dividend to $0.19 per share

Published 24/07/2025, 15:02
Encompass Health increases quarterly dividend to $0.19 per share

BIRMINGHAM, Ala. - Encompass Health Corp. (NYSE:EHC), an $11 billion market cap healthcare provider, announced Thursday that its board of directors has approved a $0.02 increase to the company’s quarterly dividend, bringing it to $0.19 per share. This continues the company’s 13-year track record of consistent dividend payments, according to InvestingPro data.

The dividend will be payable on October 15, 2025, to shareholders of record as of October 1, 2025, according to a press release statement from the company.

Encompass Health, which describes itself as the largest owner and operator of inpatient rehabilitation hospitals in the United States, currently operates 169 hospitals across 38 states and Puerto Rico.

The company provides rehabilitative care for patients recovering from major injuries or illnesses. Encompass Health’s national footprint includes facilities that utilize advanced technology for patient recovery.

The dividend announcement represents an approximately 11.8 percent increase from the company’s previous quarterly dividend payment.

Encompass Health noted in its statement that future dividend decisions remain subject to board approval and various factors including regulatory developments, economic conditions, and the company’s financial performance.

In other recent news, Encompass Health Corp. announced plans to build two new rehabilitation hospitals. A 40-bed facility is set to open in Cleveland, Tennessee, by 2026, while a 50-bed hospital is planned for North Las Vegas, Nevada. These expansions are part of the company’s ongoing efforts to meet the growing demand for specialized inpatient rehabilitation services. Meanwhile, a New York Times report raised safety concerns about rehabilitation hospitals, including those operated by Encompass Health, noting incidents of patient harm and below-average performance on Medicare safety measures. In analyst updates, KeyBanc Capital Markets increased its price target for Encompass Health to $135, maintaining an Overweight rating. The firm cited a supply-demand imbalance in the inpatient rehabilitation facility sector, which is expected to boost patient volume growth. Key factors include an aging population and regulatory conditions that support expansion. These developments reflect a complex landscape for Encompass Health as it navigates growth and safety challenges.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.